Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Leukemia Research|February 28, 2025
Molecular genetic characterization of mixed-phenotype acute leukemia (MPAL) with BCR::ABL1 fusionSophia Shi, Qianghua Zhou, Davidson Zhao, et al.
International Journal of Molecular Sciences|June 26, 2025
Genomic Profile and Clinical Outcomes in Acute Myeloid Leukemia with Monosomal KaryotypeCollins Wangulu, Ehsan Bahrami Hezaveh, Mojgan Zarif, et al.
Cancer Medicine|November 17, 2022
Molecular characterization of AML-MRC reveals TP53 mutation as an adverse prognostic factor irrespective of MRC-defining criteria, TP53 allelic state, or TP53 variant allele frequencyDavidson Zhao, Entsar Eladl, Mojgan Zarif, et al.
Cancers|June 28, 2023
TP53 Mutations in AML Patients Are Associated with Dismal Clinical Outcome Irrespective of Frontline Induction Regimen and Allogeneic Hematopoietic Cell TransplantationDavidson Zhao, Mojgan Zarif, Qianghua Zhou, et al.
Blood Advances|January 29, 2024
A real-world analysis of clinical outcomes in AML with myelodysplasia-related changes: a comparison of ICC and WHO-HAEM5 criteriaQianghua Zhou, Davidson Zhao, Mojgan Zarif, et al.
Leukemia Research|May 31, 2022
NPM1-mutated AML-MRC diagnosed on the basis of history of MDS or MDS/MPN frequently harbours secondary-type mutations and confers inferior outcome compared to AML with mutated NPM1Davidson Zhao, Mojgan Zarif, Entsar Eladl, et al.
Leukemia Research|September 10, 2023
AML with CEBPA mutations: A comparison of ICC and WHO-HAEM5 criteria in patients with 20% or more blastsDavidson Zhao, Qianghua Zhou, Mojgan Zarif, et al.
BMC Cancer|June 18, 2024
Oral pimonidazole unveils clinicopathologic and epigenetic features of hypoxic tumour aggressiveness in localized prostate cancerXinpei Ci, Sujun Chen, Rui Zhu, et al.
Pageof 1